Virtual Network's Login.
6th ESH Translational Research Conference
LYMPHOID MALIGNANCIES
#ESHLYMPHOID2021
GOING VIRTUAL
NEW DATES: October 14-17, 2021– E-CONFERENCE
https://lymphoid-2021.esh.live/
Chairs: Michael Hallek (Cologne), Georg Lenz (Münster), Laurie Sehn (Vancouver), Louis Staudt (Bethesda)
Advisory Board: Barbara Eichhorst (Cologne), Ricardo Dalla-Favera (New-York), Frank Morschhauser (Lille), Laura Pasqualucci (New York), Stephan Stilgenbauer (Ulm), Andrei Thomas-Tikhonenko (Philadelphia)
ABOUT THE CONFERENCE:
In view of continuing COVID-19 related challenges, the ESH “6th Translational Research Conference: Lymphoid Malignancies” will be held as a virtual event.
REGISTRATION IS OFFERED FREE OF CHARGE as a gesture of solidarity during these difficult times.
ABOUT THE PROGRAMME:
This leading-edge translational research conference will address the rapidly evolving field of lymphoid malignancies, including T- and B-cell lymphomas, and chronic lymphocytic leukaemia (CLL), from molecular pathogenesis to state-of-the-art treatment and future perspectives.
The goals of this conference are to:
– foster scientific exchange between laboratory scientists and clinicians working on lymphoid malignancies worldwide.
– foster scientific cross-fertilization between researchers and clinicians working on different diseases with partially overlapping pathogenic mechanisms such as the B cell receptor signaling, alterations of the DNA damage response, or the increasingly important dialogue of lymphoid tumour cells with their microenvironment.
– provide opportunities for leading-edge education and international networking to basic and clinical scientists, including those still in-training
A first-class selection of international speakers will guarantee the highest quality of science and a summary of the most recent developments in the biology and therapy of Lymphoid Malignancies.
LEARNING OBJECTIVES:
Improved understanding of :
– current developments in the field of molecular pathogenesis of indolent and aggressive B-cell lymphoma including CLL
– current developments in the field of the molecular pathogenesis of T-cell lymphoma
– prognostic and predictive markers and their impact in specific clinical situations
– current treatments and future therapeutic perspectives.
SCIENTIFIC TOPICS:
– B-cell development and lymphomagenesis
– Genetics of malignant lymphomas and clonal evolution
– Epigenetics in malignant lymphomas
– Deregulated proteome and metabolome
– Single cell analyses, circulating tumor DNA, MRD
– Oncogenic signaling pathways
– Utilizing oncogenic signaling therapeutically
– Immunologic approaches in the treatment of lymphomas
The programme will include:
– Plenary Sessions
– Simultaneous Meet the Experts Sessions (fully live)
– Round Table Discussions
– Brief Oral Communications
– Mentored Poster Walk (fully live)
– Ample time for in-depth discussion (fully live)
ABSTRACTS SUBMISSION IS NOW CLOSED
Abstracts:
TO ACCESS THE E-CONFERENCE PLATFORM, CLICK HERE!
TAKE A VIRTUAL TOUR OF THE E-CONFERENCE PLATFORM
With the support of*:
Premium E-Conference Partners
*********
Diamond E-Conference Partners
*********
Emerald E-Conference Partner
*********
Ruby E-Conference Partner
*********
*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.
The registration fee for the 6th Translational Research E-Conference: Lymphoid Malignancies is free.
REGISTRATION IS NOW OPEN!
Meet the Expert sessions: Registration fee: 20€
These sessions will be open to E-Conference academic biologists and clinicians registrants only. A maximum of 30 seats will be available in each session and pre-registration will therefore be required. REGISTRATION OPENINF CLOSER TO THE E-CONFERENCE
